12. Roadmap & Vision
Bricopia aims to build the world's largest biological-asset management platform by bridging biotechnology and blockchain.
Roadmap
The source whitepaper presents the following indicative roadmap, subject to change:
| Period | Milestone |
|---|---|
| 2024 | Privatization of TG Medical; FDA-registered automation platform secured. |
| 2025 | BABS framework and BRICO token system design; RWA regulatory tailwind. |
| 2026 | Whitepaper, platform launch, and first CBU tokenization cohorts. |
| 2027+ | Global cell-bank network onboarding; Foundation insurance programs scale. |
Vision
Bricopia is establishing a global cell-bank network that tokenizes stem-cell assets and creates wealth for donors, bank operators, and all stakeholders.
The platform is designed to:
- Build a global cell-banking network under a new business model.
- Release individual wealth by giving donors and operators a path to value.
- Fund social good by providing members with additional health insurance and supporting more clinical research to advance the cell-therapy industry.
Mission
Use tokenization to make biological assets secure, tradable, and globally accessible, and to ensure that everyone can fairly share in the benefits of cell-therapy progress, for better quality of life and health.